How do I treat and follow my TUNA patients

被引:12
作者
Barmoshe, Sas [1 ]
Zlotta, Alexandre R. [1 ]
机构
[1] Univ Brussels, Erasme Hosp, Dept Urol, B-1070 Brussels, Belgium
关键词
TUNA; BPH; minimally invasive therapy; radiofrequency; prostate enlargement; TURP;
D O I
10.1007/s00345-006-0091-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Transurethral needle ablation (TUNA) of the prostate is an alternative treatment for benign prostatic hyperplasia (BPH) generating temperatures around 100 degrees C leading to necrotic lesions inside the prostate. TUNA is a minimally invasive, low morbidity associated, approach that uses radiofrequency energy. The needles are covered by teflon shields that protect the urethra from thermal injury. Since the introduction of TUNA, there has been a constant upgrading of the device to improve treatment quality. The main advantage of this therapy is the possibility of an outpatient care due to its anaesthesia-free option with a prostatic block. Catheterisation after the procedure is required in 10-40% of cases. Long-term data (5 years) on TUNA demonstrate a sustained improvement of both IPSS score and urinary flow. About a quarter of patients require further intervention at 5 years' follow-up. The safety profile, along with the significant improvement in both objective and subjective parameters observed after TUNA, makes it an attractive approach for symptomatic BPH.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 35 条
[1]
Laser therapy for benign prostatic hyperplasia: a review of recent developments [J].
Aho, TF ;
Gilling, PJ .
CURRENT OPINION IN UROLOGY, 2003, 13 (01) :39-44
[2]
Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia [J].
Andersen, JT ;
Nickel, JC ;
Marshall, VR ;
Schulman, CC ;
Boyle, P .
UROLOGY, 1997, 49 (06) :839-845
[4]
Blute ML, 2001, UROLOGY, V58, P33, DOI 10.1016/S0090-4295(01)01301-2
[5]
Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials [J].
Boyle, P ;
Gould, AL ;
Roehrborn, CG .
UROLOGY, 1996, 48 (03) :398-405
[6]
Meta-analysis of randomized trials of terazosin in the treatment of benign prostatic hyperplasia [J].
Boyle, P ;
Robertson, C ;
Manski, R ;
Padley, RJ ;
Roehrborn, CG .
UROLOGY, 2001, 58 (05) :717-722
[7]
Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia [J].
Boyle, P ;
Robertson, C ;
Lowe, F ;
Roehrborn, C .
UROLOGY, 2000, 55 (04) :533-539
[8]
A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia [J].
Bruskewitz, R ;
Issa, MM ;
Roehrborn, CG ;
Naslund, MJ ;
Perez-Marrero, R ;
Shumaker, BP ;
Oesterling, JE .
JOURNAL OF UROLOGY, 1998, 159 (05) :1588-1593
[9]
Transurethral needle ablation (tuna) of the prostate: A clinical and urodynamic evaluation [J].
Campo, B ;
Bergamaschi, F ;
Corrada, P ;
Ordesi, G .
UROLOGY, 1997, 49 (06) :847-850
[10]
CAMPO B, 1995, J UROLOGY, V153, pA1220